Enhancement of p53 sequence-specific binding by DNA supercoiling
Related Experiment Video
Updated: Aug 29, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Emil Palecek1, Václav Brázda, Eva Jagelská
1Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno 612 65, Czech Republic. palecek@ibp.cz
Abstract:
Using a new competition assay, we investigated the effect of DNA negative supercoiling on the DNA sequence-specific binding (SSDB) of human wild-type (wt) p53 protein. We found that supercoiled (sc) pBluescript DNAs with different inserted p53 target sequences were stronger competitors than a mixture of scDNA pBluescript with the given 20-mer target oligodeoxynucleotide. ScDNAs were always better competitors than their linearized or relaxed forms. Two DNAs with extruded cruciforms within the target sequence were the best competitors; removal of the cruciforms resulted in a decrease of competitor strength. In contrast to the full-length wt p53, the deletion mutant p53CDelta30 and the p53 core domain (93-312 aa) showed no enhancement of p53 SSDB to scDNA, suggesting that, in addition to the p53 core domain, the C-terminal was involved in this binding. We conclude that cruciforms and DNA bends contribute to the enhancement of p53 SSDB to scDNA and that the DNA supercoiling is an important determinant in the p53 sequence-specific binding. Supercoiling may thus play a significant role in the complex p53-regulatory network.
More Related Videos
06:38High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
Published on: February 7, 2019
12:19Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
Related Concept Videos
Abnormal Proliferation
Single-Strand DNA Binding Proteins
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.